TY - JOUR
T1 - Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes
AU - Pratipanawatr, Thongchai
AU - Cusi, Kenneth
AU - Ngo, Peter
AU - Pratipanawatr, Wilailak
AU - Mandarine, Lawrence J.
AU - DeFronzo, Ralph A.
PY - 2002
Y1 - 2002
N2 - Considerable evidence suggests that skeletal muscle insulin resistance is an inherent feature of type 2 diabetes and contributes to the pathogenesis of the disease. In patients with poorly controlled diabetes, hyperglycemia is thought to produce additional insulin resistance in muscle. The magnitude and nature of hyperglycemia-induced insulin resistance is not known. The purpose of the present study was to determine the biochemical mechanisms responsible for increased insulin-stimulated glucose disposal after the achievement of tight glycemic control with a mixed-split regimen. We performed hyperinsulinemic-euglycemic clamps with indirect calorimetry and vastus lateralis muscle biopsies in eight type 2 diabetic patients who had poor glycemic control (HbA1c 10.1%) and again after 3 months of intensive insulin therapy designed to produce near-normoglycemia (HbA1c 6.6%). Improved glycemic control increased insulin-stimulated glucose disposal (5.16 ± 0.32 vs. 3.69 ± 0.33 mg · kg-1 · min-1; P < 0.01); nonoxidative glucose disposal, which primarily reflects glycogen synthesis (2.11 ± 0.26 vs. 0.90 ± 0.16 mg · kg-1 · min-1; P < 0.01); and glycogen synthase fractional velocity (0.094 ± 0.017 vs. 0.045 ± 0.007; P < 0.05). There was no improvement in insulin-stimulated glucose oxidation (3.05 ± 0.25 vs. 2.79 ± 0.20 mg · kg-1 · min-1), hexokinase II mRNA expression (increase over basal values), or hexokinase II enzymatic activity (0.51 ± 0.16 vs. 0.42 ± 0.18 pmol · min-1 · μg-1 protein). All of the increase in insulin-stimulated glucose disposal could be accounted for by increased glycogen synthesis, which is likely attributable to increased activation of glycogen synthase by insulin.
AB - Considerable evidence suggests that skeletal muscle insulin resistance is an inherent feature of type 2 diabetes and contributes to the pathogenesis of the disease. In patients with poorly controlled diabetes, hyperglycemia is thought to produce additional insulin resistance in muscle. The magnitude and nature of hyperglycemia-induced insulin resistance is not known. The purpose of the present study was to determine the biochemical mechanisms responsible for increased insulin-stimulated glucose disposal after the achievement of tight glycemic control with a mixed-split regimen. We performed hyperinsulinemic-euglycemic clamps with indirect calorimetry and vastus lateralis muscle biopsies in eight type 2 diabetic patients who had poor glycemic control (HbA1c 10.1%) and again after 3 months of intensive insulin therapy designed to produce near-normoglycemia (HbA1c 6.6%). Improved glycemic control increased insulin-stimulated glucose disposal (5.16 ± 0.32 vs. 3.69 ± 0.33 mg · kg-1 · min-1; P < 0.01); nonoxidative glucose disposal, which primarily reflects glycogen synthesis (2.11 ± 0.26 vs. 0.90 ± 0.16 mg · kg-1 · min-1; P < 0.01); and glycogen synthase fractional velocity (0.094 ± 0.017 vs. 0.045 ± 0.007; P < 0.05). There was no improvement in insulin-stimulated glucose oxidation (3.05 ± 0.25 vs. 2.79 ± 0.20 mg · kg-1 · min-1), hexokinase II mRNA expression (increase over basal values), or hexokinase II enzymatic activity (0.51 ± 0.16 vs. 0.42 ± 0.18 pmol · min-1 · μg-1 protein). All of the increase in insulin-stimulated glucose disposal could be accounted for by increased glycogen synthesis, which is likely attributable to increased activation of glycogen synthase by insulin.
UR - http://www.scopus.com/inward/record.url?scp=0036068886&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036068886&partnerID=8YFLogxK
U2 - 10.2337/diabetes.51.2.462
DO - 10.2337/diabetes.51.2.462
M3 - Article
C2 - 11812756
AN - SCOPUS:0036068886
SN - 0012-1797
VL - 51
SP - 462
EP - 468
JO - Diabetes
JF - Diabetes
IS - 2
ER -